Dosimetric impact of placement errors in optically stimulated luminescent in vivo dosimetry in radiotherapy

Introduction Studies have suggested that optically stimulated luminescent dosimeters (OSLDs) can be used for in vivo dosimetry of intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT). Clinical uncertainties such as placement error have not been thoroughly investigated. The purpose of this work was to measure OSLD placement error in a clinical sample and analyze its dosimetric impact. Methods and materials The analysis consisted of three parts: first, quantification of placement error in a clinical sample of 128 patients yielding 293 cone-beam CT (CBCT) with visible OSLDs registered to the treatment plan; Second, correlation of placement error and clinical OSLD measurements; third, simulation of dosimeter placement in the treatment plan and correlation of recalculated dose with placement error. Results In the first analysis, average placement error was 9.7 ± 9.5 mm. In the second analysis, placement error and measured-to-planned dose agreement yielded no correlation (R2 = 0.02) for a subsample of 77 CBCTs of 55 head-and-neck patients. Average placement error was 7.0 ± 6.0 mm. Several factors, including image-guided shifts, introduced uncharacterized uncertainty to the measured-to-planned dose agreement. The third analysis isolated placement error from these other effects. Average dosimetric error was −2.4 ± 19.3%. Simulated dosimetric impact was weakly correlated with placement error (R2 = 0.39). Removing outliers reduced the average dosimetric error to −2.1 ± 10.9%, marginally improving the correlation (R2 = 0.44). Conclusion Placement error can substantially impact measured-to-planned dose agreement of OSLDs in high gradient regions, demonstrating the criticality of accurate dosimeter placement for IMRT and VMAT treatments.

[1]  A. Olch,et al.  Validation of OSLD and a treatment planning system for surface dose determination in IMRT treatments. , 2014, Medical physics.

[2]  S Kry MO-A-BRB-01: TG191: Clinical Use of Luminescent Dosimeters. , 2016, Medical physics.

[3]  A Rea,et al.  In vivo dosimetry with optically stimulated luminescent dosimeters for conformal and intensity-modulated radiation therapy: A 2-year multicenter cohort study. , 2017, Practical radiation oncology.

[4]  C. Reft The energy dependence and dose response of a commercial optically stimulated luminescent detector for kilovoltage photon, megavoltage photon, and electron, proton, and carbon beams. , 2009, Medical physics.

[5]  Kari Tanderup,et al.  Adaptive error detection for HDR/PDR brachytherapy: guidance for decision making during real-time in vivo point dosimetry. , 2014, Medical physics.

[6]  D Huyskens,et al.  Practical guidelines for routine intensity-modulated radiotherapy verification: pre-treatment verification with portal dosimetry and treatment verification with in vivo dosimetry. , 2010, The British journal of radiology.

[7]  Marcel van Herk,et al.  Overview of 3-year experience with large-scale electronic portal imaging device-based 3-dimensional transit dosimetry. , 2015, Practical radiation oncology.

[8]  R. Kudchadker,et al.  Real-time in vivo rectal wall dosimetry using plastic scintillation detectors for patients with prostate cancer , 2014, Physics in medicine and biology.

[9]  D. Followill,et al.  Angular dependence of the nanoDot OSL dosimeter. , 2011, Medical physics.

[10]  A. Morgan,et al.  In vivo dosimetry in UK external beam radiotherapy: current and future usage. , 2017, The British journal of radiology.

[11]  Z Kusić,et al.  Optically stimulated luminescence in vivo dosimetry for radiotherapy: physical characterization and clinical measurements in 60Co beams , 2011, Physics in medicine and biology.

[12]  T. Nyholm,et al.  A practical approach to diode based in vivo dosimetry for intensity modulated radiotherapy. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  Michel Rouzaud,et al.  In vivo quality assurance of volumetric modulated arc therapy for ano-rectal cancer with thermoluminescent dosimetry and image-guidance. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  S. Kraft,et al.  Dose rate dependence for different dosimeters and detectors: TLD, OSL, EBT films, and diamond detectors. , 2012, Medical physics.

[15]  Ben Mijnheer,et al.  In vivo dosimetry in external beam radiotherapy. , 2013, Medical physics.

[16]  Real-time measurement of urethral dose and position during permanent seed implantation for prostate brachytherapy. , 2014, Brachytherapy.

[17]  Eric C Ford,et al.  A quantification of the effectiveness of EPID dosimetry and software-based plan verification systems in detecting incidents in radiotherapy. , 2015, Medical physics.

[18]  P. Jursinic,et al.  Characterization of optically stimulated luminescent dosimeters, OSLDs, for clinical dosimetric measurements. , 2007, Medical physics.

[19]  L A R da Rosa,et al.  Radiotherapy dosimetry using a commercial OSL system. , 2008, Medical physics.

[20]  Anatoly Rosenfeld,et al.  In vivo rectal wall measurements during HDR prostate brachytherapy with MOSkin dosimeters integrated on a trans-rectal US probe: Comparison with planned and reconstructed doses. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.